Predictions
Hudson Technolgies Inc.
Start price
Target price
Perf. (%)
€3.10
02.05.24
02.05.24
€12.13
02.05.25
02.05.25
-
30.09.21
30.09.21
Hudson Technolgies Inc.
Start price
Target price
Perf. (%)
€3.10
01.05.24
01.05.24
€12.18
01.05.25
01.05.25
-
30.09.21
30.09.21
Hudson Technolgies Inc.
Start price
Target price
Perf. (%)
€3.10
07.03.24
07.03.24
€14.71
07.03.25
07.03.25
-
30.09.21
30.09.21
Hudson Technolgies Inc.
Start price
Target price
Perf. (%)
€3.10
05.12.23
05.12.23
€15.69
05.12.24
05.12.24
-
30.09.21
30.09.21
Hudson Technolgies Inc.
Start price
Target price
Perf. (%)
€3.10
25.09.23
25.09.23
€14.12
25.09.24
25.09.24
-
30.09.21
30.09.21
Hudson Technolgies Inc.
Start price
Target price
Perf. (%)
€3.10
09.03.23
09.03.23
€13.23
09.03.24
09.03.24
-
10.03.24
10.03.24
Nestle Nam. ADR
Start price
Target price
Perf. (%)
€117.00
31.08.22
31.08.22
€108.00
30.11.22
30.11.22
-3.42%
30.11.22
30.11.22
The Alkaline Water Co.inc.
Start price
Target price
Perf. (%)
€6.78
08.07.22
08.07.22
€0.000
08.07.23
08.07.23
-23.45%
26.09.22
26.09.22
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€2.10
09.05.22
09.05.22
€3.30
09.05.23
09.05.23
-18.57%
16.05.22
16.05.22
Could be very worthwhile Investment >20% year
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€1.88
02.05.22
02.05.22
€32.00
02.05.23
02.05.23
-24.47%
02.06.22
02.06.22
Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€2.76
16.04.22
16.04.22
€0.000
16.04.23
16.04.23
-44.57%
30.04.22
30.04.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€2.76
15.04.22
15.04.22
-
15.04.23
15.04.23
-90.72%
16.04.23
16.04.23
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€1.98
11.04.22
11.04.22
€0.000
11.04.23
11.04.23
39.39%
18.04.22
18.04.22
Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€1.98
11.04.22
11.04.22
€0.000
11.04.23
11.04.23
-5.05%
02.05.22
02.05.22
Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
Nestle Nam. ADR
Start price
Target price
Perf. (%)
€111.50
10.03.22
10.03.22
€145.00
08.02.27
08.02.27
-7.55%
03.05.24
03.05.24
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Very small cyclical dependencies
Well known brand
Nestle Nam. ADR
Start price
Target price
Perf. (%)
€117.00
16.01.22
16.01.22
€100.00
16.01.23
16.01.23
-2.56%
17.01.23
17.01.23
Probably not worthwhile Investment
Below average Management
Sustainability is not important
Higher risks for its business